Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 03 Oct 2026
IZAR-1: Sonelokimab Meets Phase 3 End Points for PsA
Read Full NewsTwo-season real-world data show Arexvy reduces RSV-related MACE and COPD and asthma exacerbations in adults 60 and older, Ann Falsey, MD, says.
Guy Brusselle, MD, PhD, says that 64% of dupilumab-treated patients met composite asthma clinical remission criteria at week 24 versus 40.5% with omalizumab.
What The FDA Psychedelic Hearing Means for Psychiatrists
A new phase 4 trial, OCTAGON, will test a rapid, predefined corticosteroid-tapering schedule in patients with generalized myasthenia gravis treated with ravulizumab.
A phase 4 study is evaluating whether adults with chronic inflammatory demyelinating polyneuropathy can transition from intravenous immunoglobulin to subcutaneous efgartigimod PH20 without first experiencing disease worsening.
Real-world 12‑month results from WeSMA, a phase 4 study, showed that oral risdiplam is well tolerated in adults with SMA, with stable motor function and consistent safety findings.
New 12-month interim data showed functional gains with BBP-418 vs placebo, consistent benefit across genotype, age, and baseline pulmonary function subgroups, and a safety profile comparable to placebo.
1.
Similar survival seen with simple versus radical hysterectomy for cervical cancer
2.
Trial Questions Role of Dual Immunotherapy in First-Line NSCLC
3.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
4.
Daily physical activity, even at light intensities, linked to lower cancer risk
5.
PSA Often Unchanged With Enzalutamide Progression
1.
Oncology Communication Training for Difficult Conversations
2.
Deterministic Reprogramming of Neutrophils within Tumors: A New Frontier in Cancer Research
3.
Unlocking Life Expectancy After Subdural Hematoma: A New Hope
4.
The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology
5.
Seeing the Difference: Using Ultrasound to Distinguish Fibroadenoma from Cancer
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
1.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
2.
Understanding the causes of anemia in adults beyond nutritional deficiencies
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge